Your search returned 530 results.

Results
	161.	Administration of Panobinostat Is Associated with Increased IL-17A mRNA in the Intestinal Epithelium of HIV-1 Patients. [electronic resource] by Bjerg Christensen, Ane Dige, Anders Vad-Nielsen, Johan Brinkmann, Christel R Bendix, Mia Østergaard, Lars Tolstrup, Martin Søgaard, Ole S Rasmussen, Thomas A Randel Nyengaard, Jens Agnholt, Jørgen Denton, Paul W Producer: 20160926 In: Mediators of inflammation vol. 2015 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	162.	Phase II study of panobinostat and bortezomib in patients with pancreatic cancer progressing on gemcitabine-based therapy. [electronic resource] by Wang, Hengbing Cao, Qing Dudek, Arkadiusz Z Producer: 20120508 In: Anticancer research vol. 32 Availability: No items available. Save to lists Add to cart (remove)
	163.	Panobinostat in lymphoid and myeloid malignancies. [electronic resource] by Khot, Amit Dickinson, Michael Prince, H Miles Producer: 20140305 In: Expert opinion on investigational drugs vol. 22 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	164.	Broad activation of latent HIV-1 in vivo. [electronic resource] by Barton, Kirston Hiener, Bonnie Winckelmann, Anni Rasmussen, Thomas Aagaard Shao, Wei Byth, Karen Lanfear, Robert Solomon, Ajantha McMahon, James Harrington, Sean Buzon, Maria Lichterfeld, Mathias Denton, Paul W Olesen, Rikke Østergaard, Lars Tolstrup, Martin Lewin, Sharon R Søgaard, Ole Schmeltz Palmer, Sarah Producer: 20180829 In: Nature communications vol. 7 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	165.	Panobinostat activity in both bexarotene-exposed and -naïve patients with refractory cutaneous T-cell lymphoma: results of a phase II trial. [electronic resource] by Duvic, Madeleine Dummer, Reinhard Becker, Jürgen C Poulalhon, Nicolas Ortiz Romero, Pablo Grazia Bernengo, Maria Lebbé, Celeste Assaf, Chalid Squier, Margaret Williams, Denise Marshood, Miriam Tai, Feng Prince, H Miles Producer: 20130510 In: European journal of cancer (Oxford, England : 1990) vol. 49 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	166.	The pan-histone deacetylase inhibitor LBH589 (panobinostat) alters the invasive breast cancer cell phenotype. [electronic resource] by Fortunati, Nicoletta Marano, Francesca Bandino, Andrea Frairia, Roberto Catalano, Maria Graziella Boccuzzi, Giuseppe Producer: 20140904 In: International journal of oncology vol. 44 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	167.	Estimating the Economic Impact of Adding Panobinostat to a U.S. Formulary for Relapsed and/or Refractory Multiple Myeloma: A Budget Impact and Cost-Benefit Model. [electronic resource] by Bloudek, Lisa Roy, Anuja Kish, Jonathan K Siegel, David S Jagannath, Sundar Globe, Denise Orloski, Laurie Kuriakose, Emil T Producer: 20170427 In: Journal of managed care & specialty pharmacy vol. 22 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	168.	Bortezomib, lenalidomide, and dexamethasone with panobinostat for front-line treatment of patients with multiple myeloma who are eligible for transplantation: a phase 1 trial. [electronic resource] by Manasanch, Elisabet E Shah, Jatin J Lee, Hans C Weber, Donna M Thomas, Sheeba K Amini, Behrang Feng, Lei Berkova, Zuzana Hildebrandt, Michelle Orlowski, Robert Z Producer: 20181231 In: The Lancet. Haematology vol. 5 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	169.	Epigenetic targeting of Notch1-driven transcription using the HDACi panobinostat is a potential therapy against T-cell acute lymphoblastic leukemia. [electronic resource] by Waibel, M Vervoort, S J Kong, I Y Heinzel, S Ramsbottom, K M Martin, B P Hawkins, E D Johnstone, R W Producer: 20181211 In: Leukemia vol. 32 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	170.	Pan-histone deacetylase inhibitor panobinostat sensitizes gastric cancer cells to anthracyclines via induction of CITED2. [electronic resource] by Regel, Ivonne Merkl, Lisa Friedrich, Teresa Burgermeister, Elke Zimmermann, Wolfgang Einwächter, Henrik Herrmann, Ken Langer, Rupert Röcken, Christoph Hofheinz, Ralf Schmid, Roland Ebert, Matthias P Producer: 20121001 In: Gastroenterology vol. 143 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	171.	Phase I study evaluating the safety and efficacy of oral panobinostat in combination with radiotherapy or chemoradiotherapy in patients with inoperable stage III non-small-cell lung cancer. [electronic resource] by Takhar, Harminder S Singhal, Nimit Gowda, Raghu Penniment, Michael Takhar, Parineet Brown, Michael P Producer: 20151229 In: Anti-cancer drugs vol. 26 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	172.	Panobinostat Plus Bortezomib Versus Lenalidomide in Patients with Relapsed and/or Refractory Multiple Myeloma: A Matching-Adjusted Indirect Treatment Comparison of Survival Outcomes using Patient-level Data. [electronic resource] by Majer, Istvan van de Wetering, Gijs Polanyi, Zoltan Krishna, Arun Gray, Elisabeth Roy, Anuja Producer: 20170327 In: Applied health economics and health policy vol. 15 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	173.	Updated results of a phase 2 study of panobinostat combined with melphalan, thalidomide and prednisone (MPT) in relapsed/refractory multiple myeloma. [electronic resource] by Offidani, Massimo Corvatta, Laura Liberati, Anna Marina Pulini, Stefano Ballanti, Stelvio Bringhen, Sara Producer: 20190111 In: Leukemia & lymphoma vol. 59 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	174.	LBH589 induces up to 10-fold SMN protein levels by several independent mechanisms and is effective even in cells from SMA patients non-responsive to valproate. [electronic resource] by Garbes, Lutz Riessland, Markus Hölker, Irmgard Heller, Raoul Hauke, Jan Tränkle, Christian Coras, Roland Blümcke, Ingmar Hahnen, Eric Wirth, Brunhilde Producer: 20091109 In: Human molecular genetics vol. 18 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	175.	Effects of cisplatin and panobinostat on human mesothelial (Met-5A) and malignant pleural mesothelioma (MSTO-211H) cells. [electronic resource] by Gultekin, K E Yurdakonar, M K Yaman, E Yuce, U S Yilmaz, A Alp, E Celik, A Demiroz, S M Onen, H I Producer: 20140716 In: Genetics and molecular research : GMR vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	176.	A clinical investigation of inhibitory effect of panobinostat on CYP2D6 substrate in patients with advanced cancer. [electronic resource] by Feld, Ronald Woo, Margaret M Leighl, Natasha Shepherd, Frances A Beck, J Thaddeus Zhao, Lihui Gazi, Lucien Hengelage, Thomas Porro, Maria Grazia Nayak, Asha Producer: 20140428 In: Cancer chemotherapy and pharmacology vol. 72 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	177.	Panobinostat PK/PD profile in combination with bortezomib and dexamethasone in patients with relapsed and relapsed/refractory multiple myeloma. [electronic resource] by Mu, Song Kuroda, Yoshiaki Shibayama, Hirohiko Hino, Masayuki Tajima, Takeshi Corrado, Claudia Lin, Rong Waldron, Edward Binlich, Florence Suzuki, Kenshi Producer: 20161013 In: European journal of clinical pharmacology vol. 72 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	178.	Panobinostat for the treatment of acute myelogenous leukemia. [electronic resource] by Morabito, Fortunato Voso, Maria Teresa Hohaus, Stefan Gentile, Massimo Vigna, Ernesto Recchia, Anna Grazia Iovino, Lorenzo Benedetti, Edoardo Lo-Coco, Francesco Galimberti, Sara Producer: 20170314 In: Expert opinion on investigational drugs vol. 25 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	179.	Combined treatment with the histone deacetylase inhibitor LBH589 and a splice-switch antisense oligonucleotide enhances SMN2 splicing and SMN expression in Spinal Muscular Atrophy cells. [electronic resource] by Pagliarini, Vittoria Guerra, Marika Di Rosa, Valentina Compagnucci, Claudia Sette, Claudio Producer: 20200831 In: Journal of neurochemistry vol. 153 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	180.	Panobinostat: The Small Molecule Metalloenzyme Inhibitor with Marvelous Anticancer Activity. [electronic resource] by Ganai, Shabir Ahmad Producer: 20160722 In: Current topics in medicinal chemistry vol. 16 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

First
Previous
1
2
3
4
5
6
7
8
9
10
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 530 results.